COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis.

Peric, Stojan; Rankovic, Milos; Bozovic, Ivo; Radosavljevic, Vanja; Marjanovic, Ivan; Basta, Ivana; Lavrnic, Dragana

Peric, Stojan; Rankovic, Milos; Bozovic, Ivo; Radosavljevic, Vanja; Marjanovic, Ivan; Basta, Ivana; Lavrnic, Dragana.

Afiliação

Peric S; University of Belgrade-Faculty of Medicine, University Clinical Center of Serbia-Neurology Clinic, Belgrade, Serbia.
Rankovic M; University Clinical Centre of Serbia - Neurology Clinic, Dr Subotic Street 6, 11000, Belgrade, Serbia.
Bozovic I; University Clinical Centre of Serbia - Neurology Clinic, Dr Subotic Street 6, 11000, Belgrade, Serbia. ivo.bozovic20@gmail.com.
Radosavljevic V; University Clinical Centre of Serbia - Neurology Clinic, Dr Subotic Street 6, 11000, Belgrade, Serbia.
Marjanovic I; Private Consultant in Neurology, Milan, Italy.
Basta I; University of Belgrade-Faculty of Medicine, University Clinical Center of Serbia-Neurology Clinic, Belgrade, Serbia.
Lavrnic D; University of Belgrade-Faculty of Medicine, University Clinical Center of Serbia-Neurology Clinic, Belgrade, Serbia.

Acta Neurol Belg ; 123(2): 529-536, 2023 Apr.

Article em En | MEDLINE | ID: mdl-36279094

Assuntos

COVID-19; Miastenia Gravis; Feminino; Humanos; Idoso; Masculino; SARS-CoV-2; Autoanticorpos; COVID-19/prevenção & controle; Miastenia Gravis/diagnóstico; Vacinação/efeitos adversos

Palavras-chave

COVID-19 infection; Myasthenia gravis; SARS-CoV-2; Vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Miastenia Gravis Limite: Aged / Female / Humans / Male Idioma: En Revista: Acta Neurol Belg Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google